President, R&D & CMO
Wed, Apr 1, 2026
Apr 1
300 shares @ $31.07
Decreased holdings by -100.00%
Net across this filing: 0.00% (+0 shares)
33rd largest trade (out of 50)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 5% below 200-day moving average
Small Cap stock — insider trades carry more weight